Literature DB >> 17213243

Quality of paediatric rehabilitation from the parent perspective: validation of the short Measure of Processes of Care (MPOC-20) in the Netherlands.

Renate C Siebes1, Gerard H Maassen, Lex Wijnroks, Marjolijn Ketelaar, Petra E M van Schie, Jan Willem Gorter, Adri Vermeer.   

Abstract

OBJECTIVE: In the present study we aim to assess the reliability and validity of the 20-item version of the Dutch Measure of Processes of Care (MPOC).
DESIGN: The reliability, concurrent validity, predictive validity and construct validity of the Dutch MPOC-20 were determined. A subset of MPOC-20 data was extracted from a large Dutch MPOC (56-item version) database.
SUBJECTS: Participants were 405 mothers and 22 fathers of children aged 1-18 years recruited through nine paediatric rehabilitation centres in the Netherlands. MAIN MEASURES: The participants filled out the MPOC-20 items, the Client Satisfaction Questionnaire (CSQ), and two additional questions about satisfaction with services and the amount of stress they experienced.
RESULTS: The internal consistency analyses (alphas 0.75-0.87) and the test-retest analyses (intraclass correlation coefficients (ICCs) 0.78-0.91) showed that the Dutch MPOC-20 is a reliable tool. The concurrent validity of the Dutch MPOC-20 was confirmed by positive correlations between MPOC-20 scale scores and the CSQ (r 0.39-0.69), and between MPOC-20 scale scores and an overall satisfaction variable (r 0.37-0.66). The predictive validity of the Dutch MPOC-20 was supported by moderately negative correlations between MPOC-20 scores and a stress variable (r -0.27 to -0.44). The construct validity of the Dutch MPOC-20 was confirmed by significant scale intercorrelations (r 0.41-0.84) and a factor analysis.
CONCLUSIONS: The 20-item version of the MPOC (Dutch MPOC-20) is a reliable and valid measure of the family-centredness of paediatric rehabilitation.

Entities:  

Mesh:

Year:  2007        PMID: 17213243     DOI: 10.1177/0269215506071280

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  5 in total

1.  Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation.

Authors:  Mieke Aldenhoven; Brigitte T A van den Broek; Robert F Wynn; Anne O'Meara; Paul Veys; Attilio Rovelli; Simon A Jones; Rossella Parini; Peter M van Hasselt; Marleen Renard; Victoria Bordon; Tom J de Koning; Jaap Jan Boelens
Journal:  Blood Adv       Date:  2017-11-07

2.  Reorganizing pediatric rehabilitation services to improve accessibility: do we sacrifice quality?

Authors:  Chantal Camden; Bonnie Swaine; Sylvie Tétreault; Marie-Michèle Brodeur
Journal:  BMC Health Serv Res       Date:  2010-08-05       Impact factor: 2.655

3.  Study protocol for a multicentre randomized controlled trial on effectiveness of an outpatient multimodal rehabilitation program for adolescents with chronic musculoskeletal pain (2B Active).

Authors:  Carolien Dekker; Mariëlle E J B Goossens; Caroline H G Bastiaenen; Jeanine A M C F Verbunt
Journal:  BMC Musculoskelet Disord       Date:  2016-07-28       Impact factor: 2.362

4.  Protocol of changes induced by early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (e-HABIT-ILE) in pre-school children with bilateral cerebral palsy: a multisite randomized controlled trial.

Authors:  Rodrigo Araneda; Stephane V Sizonenko; Christopher J Newman; Mickael Dinomais; Gregoire Le Gal; Daniela Ebner-Karestinos; Julie Paradis; Anne Klöcker; Geoffroy Saussez; Josselin Demas; Rodolphe Bailly; Sandra Bouvier; Emmanuel Nowak; Andrea Guzzetta; Inmaculada Riquelme; Sylvain Brochard; Yannick Bleyenheuft
Journal:  BMC Neurol       Date:  2020-06-12       Impact factor: 2.474

5.  Functional, neuroplastic and biomechanical changes induced by early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (e-HABIT-ILE) in pre-school children with unilateral cerebral palsy: study protocol of a randomized control trial.

Authors:  R Araneda; S V Sizonenko; C J Newman; M Dinomais; G Le Gal; E Nowak; A Guzzetta; I Riquelme; S Brochard; Y Bleyenheuft
Journal:  BMC Neurol       Date:  2020-04-14       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.